Numerous studies have shown that TGF-b1 signaling governs the migration and invasion capacity of many human cancers by affecting the expression of EMT indicators, such as breast cancer [28], lung cancer [29], ovarian cancer [26], and prostate cancer [30], by affecting the expression of EMT indicators. This evidence concerns the gene TGFB1 and ovarian carcinoma.